CDK4 and osteosarcoma: The enhanced expression of the cyclin D/CDK4/Rb pathway inevitably contributed to the rampant survival and proliferation of cancer cells within a large variety of malignant categories, especially osteosarcoma [13] and synovial sarcoma [14].